Literature DB >> 19445023

Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report.

S M Sorscher1.   

Abstract

Acinar cell carcinoma of the pancreas is rare tumour with a generally poor prognosis. There are very few reports of tumour regression following chemotherapy. In this case report, a patient with metastatic acinar cell carcinoma in the liver developed progressive disease after cisplatin/etoposide and then had progressive disease after weekly paclitaxel chemotherapy. However, his tumour then responded to gemcitibine/5-flourouracil/leucovorin chemotherapy. Herein, previously described chemotherapy regimens used for this rare tumour are reviewed. This case represents the first reported metastatic acinar cell carcinoma responding to this regimen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19445023     DOI: 10.1111/j.1365-2354.2008.01014.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Acinar Cell Carcinoma Responding to Carboplatin/Etoposide Chemotherapy.

Authors:  Steven M Sorscher
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.

Authors:  Yusuke Kanemasa; Terumi Kamisawa; Taku Tabata; Sawako Kuruma; Susumu Iwasaki; Kazuro Chiba; Go Kuwata; Takashi Fujiwara; Hideto Egashira; Koichi Koizumi; Junko Fujiwara; Takeo Arakawa; Kumiko Momma; Hirofumi Rokutan; Shinichiro Horiguchi; Tsunekazu Hishima
Journal:  Clin J Gastroenterol       Date:  2013-09-05

3.  Pancreatic acinar cell carcinoma with extensive tumor embolism at the trunk of portal vein and pancreatic intraductal infiltration.

Authors:  Akihiko Kida; Koichiro Matsuda; Kai Takegoshi; Mitsuru Matsuda; Akito Sakai; Yatsugi Noda
Journal:  Clin J Gastroenterol       Date:  2017-09-18

4.  An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

Authors:  Matthew D Armstrong; Daniel Von Hoff; Bruce Barber; Laura A Marlow; Christina von Roemeling; Simon J Cooper; Patrick Travis; Elizabeth Campbell; Ricardo Paz-Fumagalli; John A Copland; Gerardo Colon-Otero
Journal:  J Cancer       Date:  2011-03-08       Impact factor: 4.207

5.  Pancreatic Acinar Cell Carcinoma.

Authors:  Dominique Béchade; Marie Desjardin; Emma Salmon; Grégoire Désolneux; Yves Bécouarn; Serge Evrard; Marianne Fonck
Journal:  Case Rep Gastroenterol       Date:  2016-05-02

6.  Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing Regimens.

Authors:  Hideaki Takahashi; Masafumi Ikeda; Satoshi Shiba; Hiroshi Imaoka; Akiko Todaka; Kazuhiko Shioji; Kei Yane; Yasushi Kojima; Satoshi Kobayashi; Akinori Asagi; Masato Ozaka; Ryoji Takada; Yoshikuni Nagashio; Shigeru Horiguchi; Akiyoshi Kasuga; Eiichiro Suzuki; Takeshi Terashima; Makoto Ueno; Chigusa Morizane; Junji Furuse
Journal:  Pancreas       Date:  2021-01-01       Impact factor: 3.243

7.  Prolonged Survival in a Patient with a Pancreatic Acinar Cell Carcinoma.

Authors:  Anne Ploquin; Capucine Baldini; Perrine Vuagnat; Samira Makhloufi; Christophe Desauw; Mohamed Hebbar
Journal:  Case Rep Oncol       Date:  2015-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.